Vesicoureteral reflux: who benefits from correction

Area of Science:

• Pediatric Urology
• Nephrology
• Evidence-Based Medicine

Background:

• A shift towards therapeutic nihilism regarding surgical treatment for vesicoureteral reflux (VUR) is emerging.
• Evidence-based reviews and randomized controlled trials (RCTs) are questioning the efficacy of surgical interventions and prophylactic antibiotics for VUR in children.
• Prophylactic antibiotics, previously a first-line therapy, have shown no significant effect in reducing urinary tract infections (UTIs) in children with VUR.

Purpose of the Study:

• To evaluate the current therapeutic landscape for pediatric vesicoureteral reflux.
• To identify key factors influencing the spontaneous resolution of VUR.
• To assess the predictive value of various clinical parameters for VUR outcomes.

Main Methods:

• Review of evidence-based literature and randomized controlled trials concerning VUR treatment.
• Analysis of factors influencing spontaneous resolution of VUR.
• Exploration of predictive models (nomograms) for VUR resolution.

Main Results:

• VUR surgical treatment efficacy is under scrutiny, with a rise in therapeutic nihilism.
• Prophylactic antibiotics demonstrate no significant benefit in preventing UTIs in pediatric VUR patients.
• Reflux grade is the primary predictor of VUR resolution; high-grade VUR is less likely to resolve spontaneously.

Conclusions:

• Spontaneous resolution of VUR is influenced by multiple factors including grade, bladder dynamics, patient age, sex, and kidney status.
• Computer models incorporating these factors can improve predictions of spontaneous VUR resolution.
• The findings necessitate a re-evaluation of current VUR management strategies, moving beyond traditional approaches.